BVD-523
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for BVD-523, covering 2019-06-17 to 2021-11-11. Get the full timeline:
Most recent: Clinical Trial Update: A Phase II Study of BVD-523 in Metastatic Uveal Melanoma [Phase 2]